Pendal Group LTD Haemonetics Corp Transaction History

Pendal Group LTD

  • $12.2 Billion
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 02, 2020
SELL
$75.65 - $93.58 $348,141 - $430,655
-4,602 Closed
0 $0
Q2 2020

Aug 07, 2020
BUY
$84.96 - $118.91 $390,985 - $547,223
4,602 New
4,602 $412,000
Q1 2020

May 04, 2020
SELL
$74.34 - $121.82 $54,045 - $88,563
-727 Closed
0 $0
Q4 2019

Feb 06, 2020
BUY
$114.37 - $129.46 $83,146 - $94,117
727 New
727 $83,000

Others Institutions Holding HAE

# of Institutions
332
Shares Held
53.8M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.87B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Pendal Group LTD Portfolio

Follow Pendal Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email